BenzingaTue, 09 Jun 2026 17:31:21 GMTNew Partnership Gives Cartesian Therapeutics Another Shot At Autoimmune Disease MarketRNAC-5.30%
Zacks Investment ResearchThu, 30 Apr 2026 13:35:17 GMTCartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue EstimatesRNAC-5.30%
Zacks Investment ResearchMon, 20 Apr 2026 13:02:15 GMTCartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?RNAC-5.30%
Seeking AlphaTue, 14 Apr 2026 15:41:45 GMTCartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptRNAC-5.30%